View More Recent Stories

Sep 20, 2024 08:00AM Samsung Bioepis and Biogen (BIIB) Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ
Sep 12, 2024 07:30AM Biogen (BIIB) Appoints Lloyd B. Minor and Mene Pangalos to its Board
Sep 5, 2024 08:53AM BMO Capital Reiterates Outperform Rating on Biogen (BIIB)
Sep 4, 2024 07:32AM Biogen (BIIB) Reports Positive Topline Results from Study of Higher Dose Regimen of Nusinersen
Aug 22, 2024 08:06AM BMO Capital Reiterates Outperform Rating on Biogen (BIIB)
Aug 6, 2024 06:46AM Biogen (BIIB) PT Lowered to $251 at Mizuho
Aug 5, 2024 07:50AM Biogen (BIIB) PT Lowered to $302 at Truist Securities
Aug 2, 2024 06:24AM Biogen (BIIB) PT Raised to $292 at RBC Capital
Aug 1, 2024 11:44AM Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
Aug 1, 2024 07:27AM Biogen (BIIB) tops Q2 expectations, raises profit guidance
Aug 1, 2024 06:59AM Biogen (BIIB) Tops Q2 EPS by 127c; profit guidance raised
Jul 30, 2024 05:00PM Biogen (BIIB) Reports New Data Showing Three Years of Continuous Treatment with Dual-Acting LEQEMBI Continues to Significantly Benefit Early Alzheimer's Disease Patients
Jul 30, 2024 07:31AM Biogen (BIIB), Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 29, 2024 06:56AM Biogen (BIIB) PT Lowered to $294 at Baird
Jul 29, 2024 06:16AM Eisai slumps 13% as EU regulators reject Alzheimer’s treatment developed with Biogen
Jul 26, 2024 12:18PM Goldman Sachs Reiterates Buy Rating on Biogen (BIIB), 'We next await the August 1 earnings call'
Jul 26, 2024 11:27AM Midday movers: Bristol-Myers, 3M and Deckers rise; Dexcom falls
Jul 26, 2024 10:40AM Biogen (BIIB) PT Lowered to $307 at Piper Sandler
Jul 26, 2024 10:10AM Biogen (BIIB) PT Lowered to $282 at RBC Capital
Jul 26, 2024 07:22AM Biogen (BIIB): EMA has adopted a negative opinion on MAA of Lecanemab for early Alzheimer’s disease
Jul 24, 2024 07:43AM SAGE Therapeutics (SAGE) Falls 24% After Phase 2 KINETIC 2 Study of SAGE-324 Fails
Jul 24, 2024 06:32AM SAGE Therapeutics (SAGE) and Biogen (BIIB) Report Topline Results from Phase 2 KINETIC 2 Study of SAGE-324
Jul 12, 2024 07:22AM Biogen (BIIB) PT Lowered to $313 at Piper Sandler
Jul 11, 2024 01:32PM Biogen: RBC says 'very likely' that Leqembi will be approved in Europe
Jul 11, 2024 06:37AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB), very likely Leqembi will be approved in Europe
Jul 2, 2024 01:55PM Biogen (BIIB) trades lower after after Lilly's Alzheimer's drug is approved
Jul 2, 2024 09:17AM Biogen (BIIB) Completes Acquisition of Human Immunology Biosciences
Jun 26, 2024 03:25PM RBC Capital on Biogen (BIIB): 'We See An EU Approval In 3Q24 As Likely'
Jun 26, 2024 05:24AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)
Jun 24, 2024 07:30AM Biogen (BIIB) Announces TOFIDENCE Approved in the EU
Jun 12, 2024 10:10AM Scotiabank Reiterates Sector Outperform Rating on Biogen (BIIB)
Jun 9, 2024 10:13PM Eisai, Biogen (BIIB) announced FDA acceptance of sBLA for LEQEMBI IV maintenance dosing
View More Recent Stories